PharmEasy: A difficult prognosis
Parent API Holdings seems to be banking on FOMO to raise public money at 500% more than what it was valued at nine months ago.
Why read this story?
Editor's note: API Holdings, parent of online pharmacy platform PharmEasy, is on track to set a record for the fastest listing by a unicorn. In April this year, the company raised $350 million from investors, taking it past the billion dollar mark for the first time. Earlier this month, it filed its draft IPO prospectus to float a public issue in the current fiscal year itself. That, if it happens, will see beauty products company Nykaa—which became a $1 billion company in March last year and went on to list earlier this month—lose the tag for the fastest listing by a unicorn. Besides, API Holdings is not looking to raise any small sum. It wants to issue fresh equity to raise about $900 million. It last raised funds in October, to be valued at $5.6 billion, and is working on a pre-IPO placement that is likely to determine the final size and pricing of its issue. Trading in unlisted shares of the company values it at over $9 billion, a whopping 500% increase in the last nine months. The BSE Healthcare index, …
More in Internet
You may also like
How India’s retail shareholders are being left holding the can
Swiggy and Ola Electric’s plans to return to the public markets soon after big-bang IPOs leave investors with dilution, little prospect of returns and plenty of questions.
Duroflex wakes up as Wakefit closes in on an IPO
The six-decade old mattress maker files its draft IPO papers just as Wakefit wins approval for a public market debut—setting up a bruising battle for the No. 2 spot.
Mankind needs to get its mojo back
Once a stock market darling, the pharma company is bearing the brunt of a costly acquisition.